Anti-GP142/ GPR142/ GPRg1b monoclonal antibody
Anti-GP142/ GPR142/ GPRg1b antibody for FACS & in-vivo assay
Go to GPR142/GPR142 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0509-Ab-1/ GM-Tg-hg-MP0509-Ab-2 | Anti-Human GPR142 monoclonal antibody | Human |
GM-Tg-rg-MP0509-Ab-1/ GM-Tg-rg-MP0509-Ab-2 | Anti-Rat GPR142 monoclonal antibody | Rat |
GM-Tg-mg-MP0509-Ab-1/ GM-Tg-mg-MP0509-Ab-2 | Anti-Mouse GPR142 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0509-Ab-1/ GM-Tg-cynog-MP0509-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GPR142 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0509-Ab-1/ GM-Tg-felg-MP0509-Ab-2 | Anti-Feline GPR142 monoclonal antibody | Feline |
GM-Tg-cang-MP0509-Ab-1/ GM-Tg-cang-MP0509-Ab-2 | Anti-Canine GPR142 monoclonal antibody | Canine |
GM-Tg-bovg-MP0509-Ab-1/ GM-Tg-bovg-MP0509-Ab-2 | Anti-Bovine GPR142 monoclonal antibody | Bovine |
GM-Tg-equg-MP0509-Ab-1/ GM-Tg-equg-MP0509-Ab-2 | Anti-Equine GPR142 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0509-Ab-1/ GM-Tg-hg-MP0509-Ab-2; GM-Tg-rg-MP0509-Ab-1/ GM-Tg-rg-MP0509-Ab-2; GM-Tg-mg-MP0509-Ab-1/ GM-Tg-mg-MP0509-Ab-2; GM-Tg-cynog-MP0509-Ab-1/ GM-Tg-cynog-MP0509-Ab-2; GM-Tg-felg-MP0509-Ab-1/ GM-Tg-felg-MP0509-Ab-2; GM-Tg-cang-MP0509-Ab-1/ GM-Tg-cang-MP0509-Ab-2; GM-Tg-bovg-MP0509-Ab-1/ GM-Tg-bovg-MP0509-Ab-2; GM-Tg-equg-MP0509-Ab-1/ GM-Tg-equg-MP0509-Ab-2 |
Products Name | Anti-GPR142 monoclonal antibody |
Format | mab |
Target Name | GPR142 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GPR142 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species GP142/ GPR142/ GPRg1b VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMAAV000348 | human GPR142 AAV plasmid |
ORF Viral Vector | vGMAAV000348 | human GPR142 AAV particle |
Target information
Target ID | GM-MP0509 |
Target Name | GPR142 |
Gene ID | 350383,217302,501735,100427619,483287,101088197,538511,100060761 |
Gene Symbol and Synonyms | GPR142,GPRg1b,PGR2,RGD1559926 |
Uniprot Accession | Q7Z601 |
Uniprot Entry Name | GP142_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000257008 |
Target Classification | GPCR |
The target: GPR142, gene name: GPR142, also named as GPRg1b, PGR2. GPR142 is a member of the rhodopsin family of G protein-coupled receptors (GPRs) (Fredriksson et al., 2003 [PubMed 14623098]).[supplied by OMIM, Mar 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.